EventsMOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Published
This submission belongs to the session 07. TECHLAW.SCI-06: Technol., & Law Sci. Congresses, Bayonne, France-Miami, USA, 2022. of the event MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed.
Published date
03 Nov, 2022
Academic Editor
author-avatarHumbert G. Díaz
Citation
Shan He, Research and Entrepreneurship Opportunities on Artificial Intelligence Applications to Nanoparticles Design for Neurological Diseases Treatment, in Proceedings of MOL2NET'22, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 8th ed., 1 January–15 January 2023, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-08-13490
Share
Email
Facebook
Twitter
LinkedIn

Research and Entrepreneurship Opportunities on Artificial Intelligence Applications to Nanoparticles Design for Neurological Diseases Treatment

Shan He 1,2
1. Department of Organic and Inorganic Chemistry, Faculty of Science and Technology, University of the Basque Country UPV/EHU, P.O.Box 644, 48080 Bilbao, Spain.
2. IKERDATA S.L, ZITEK, UPV/EHU, Rectorate Building, n0 6, Leioa, Greater Bilbao, Basque Country, Spain.
Abstract

Artificial Intelligent (AI) and Machine Learning (ML) are developing significant advances and gaining importance information processing in a huge number of fields such as chemical, pharmaceutical, biological etc. The Perturbation Theory (PT) is commonly combined with ML in order to generate PTML models and has been used in various disciplines to predict the biological activity of drugs and nanoparticles. In addition, this powerful tool has showed promising results in the field of nanoinformatics. As a consequence of evident achievements on a wide range of predictive tasks, ML techniques are attracting significant interest across a variety of stakeholders. Therefore, In this review different type of application of machine learning in nanoparticles involve in neurological diseases will be discussed.

In addition, different startup, spin-off, Small and Medium Enterprises (SMEs), and also some BigPharman, Tech companies, Nanoform-Drug Particle Engineering, Precision Medicine, NanosticsNanotechnology-Baed Diagnostic etc. are developing AI-based nanomedicine, nanotechnology, brain diseases so on. This communication also lists some of these startup companies.

Keywords
Artificial Intelligence
Machine Learning
Nanotechnology
Neurological diseases
Starup
Spin-off
Manuscript
Applications of Artificial Intelligence in nanoscience.
Multicriteria Methodology Based on Hierarchical Process Analysis (AHP) for the Selection and Evaluation of Companies in an Entrepreneurial Project Accelerator